Simplex Trading’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,905
Closed -$65.1K 9841
2026
Q1
$56.1K Sell
6,905
-21,158
-75% -$182K ﹤0.01% 5746
2025
Q4
$292K Sell
28,063
-118,108
-81% -$1.24M ﹤0.01% 3846
2025
Q3
$1.29M Buy
146,171
+141,962
+3,373% +$1.01M ﹤0.01% 2783
2025
Q2
$24K Sell
4,209
-10,654
-72% -$65.3K ﹤0.01% 6607
2025
Q1
$98K Buy
+14,863
New +$116K ﹤0.01% 5078
2024
Q2
Sell
-23,746
Closed -$488K 9340
2024
Q1
$506K Buy
23,746
+16,201
+215% +$315K ﹤0.01% 3851
2023
Q4
$108K Buy
7,545
+7,330
+3,409% +$72.1K ﹤0.01% 5302
2023
Q3
$1K Sell
215
-4,228
-95% -$42.9K ﹤0.01% 8335
2023
Q2
$47K Buy
+4,443
New +$52.5K ﹤0.01% 5913
2021
Q4
Sell
-5,070
Closed -$82.1K 10952
2021
Q3
$110K Sell
5,070
-1,597
-24% -$30.1K ﹤0.01% 6482
2021
Q2
$139K Buy
6,667
+3,969
+147% +$98.5K ﹤0.01% 6252
2021
Q1
$76K Sell
2,698
-15,048
-85% -$476K ﹤0.01% 6112
2020
Q4
$579K Buy
+17,746
New +$624K ﹤0.01% 3229
2020
Q3
Sell
-17,287
Closed -$382K 8135
2020
Q2
$281K Buy
17,287
+13,944
+417% +$201K ﹤0.01% 3604
2020
Q1
$33K Buy
3,343
+2,416
+261% +$27.7K ﹤0.01% 5548
2019
Q4
$12K Buy
+927
New +$13.7K ﹤0.01% 6286
2019
Q2
Sell
-267
Closed -$4.43K 7458
2019
Q1
$4K Sell
267
-10,331
-97% -$159K ﹤0.01% 6568
2018
Q4
$148K Buy
10,598
+6,008
+131% +$79.6K ﹤0.01% 3473
2018
Q3
$80K Buy
4,590
+3,260
+245% +$62.5K ﹤0.01% 4673
2018
Q2
$24K Buy
+1,330
New +$22.5K ﹤0.01% 5721

Other funds holding KURA

Simplex Trading's KURA Position: Q2 2026 in Review

Simplex Trading sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 6,905 shares — an estimated $65.1K sold.

Simplex Trading first reported a position in KURA in Q2 2018 and held it in 20 quarters. The position peaked at $1.29M in Q3 2025. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Simplex Trading reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 6,905 Kura Oncology shares in Q2 2026, an estimated $65.1K.
  • Simplex Trading first reported a position in Kura Oncology in Q2 2018 and held it in 20 quarters.
  • Simplex Trading's Kura Oncology position peaked at $1.29M in Q3 2025.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.